Eri Sasaki
Hachioji, 1920392, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Systemic mRNA Delivery into the Muscle of Duchenne Muscular Dystrophy Model Mice Using Alpha-Dystroglycan Binding Peptide Modified Lipid Nanoparticles.
Journal: Biological & pharmaceutical bulletin
Published: May 28, 2025
Alpha-dystroglycan binding peptide A2G80-modified stealth liposomes as a muscle-targeting carrier for Duchenne muscular dystrophy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 22, 2020
Development of A2G80 peptide-gene complex for targeted delivery to muscle cells.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 08, 2020
Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice.
Journal: ACS medicinal chemistry letters
Published: April 15, 2019
PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 26, 2017
Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural Modification.
Journal: ACS medicinal chemistry letters
Published: April 18, 2017
Mammalian target of rapamycin (mTOR) complex 2 regulates filamin A-dependent focal adhesion dynamics and cell migration.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: September 28, 2015
Graphiumins, new thiodiketopiperazines from the marine-derived fungus Graphium sp. OPMF00224.
Journal: The Journal of antibiotics
Published: December 11, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026